JAK1

There are 51 papers on JAK1 in aging research: 1 trial and 8 observational studies in people, 28 in animals, 11 in cells, 1 review. The newest story, Oct 26, 2026: “Ruxolitinib reduces retinal blood vessel leakage in rats”.

Gene

51 papers study it9 findings

HGNCNCBI GeneTaxon

2 new papers in 30 daysSee all 51 papers on JAK1

At a glance

The findings reach people, from one lab or study. 6 independent labs in 5 countries; 154 trials, 14 with no results posted.

“higher JAK1 expression conferred increased risk of AF (OR = 1.255, p = 0.043)”
Differential risk of adverse drug reactions with baricitinib across age groups: integrating real-world pharmacovigilance and genetic causal inferenceTherapeutic advances in drug safety2025doi:10.1177/20420986251406106

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 6 independent labs in 5 countries
  • 154 trials, 14 with no results posted
  • Funders: National Research Foundation of Korea and others
  • 2 of 8 findings with company ties
  • 105 of 154 trials sponsored by developers of drugs aimed at it
  • Human trial1
  • Humans8
  • Animals28
  • Cells11
  • In silico2

Effects

6

Resistance to sunitinib

mediatesin human cells1

1 study
  1. JAK1 mediates resistance to sunitinib in human cells (non-senescent cells; sunitinib-induced JAK1 phosphorylation).

    Cellsnon-senescent cells; sunitinib-induced JAK1 phosphorylationhuman dermal fibroblast

    Sunitinib selectively killed senescent cells in the lab

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Ejection fraction

upin mice1

1 study
  1. JAK1 increases ejection fraction in mice (shown by cardiomyocyte-restricted deletion) (31.12±6.90 % vs. 36.41±6.61 %).

    Animalsshown by cardiomyocyte-restricted deletionmales

Dilated cardiomyopathy

downin mice1

1 study
  1. JAK1 protects against dilated cardiomyopathy in mice (shown by cardiomyocyte-restricted deletion).

    Animalsshown by cardiomyocyte-restricted deletion

More on Dilated cardiomyopathy

TLR3

mediatesin human cells1

1 study
  1. JAK1 mediates TLR3 in human cells (linking IFN-β activity to TLR3 expression).

    Cellslinking IFN-β activity to TLR3 expression

More on TLR3

Cellular senescence

is required forin human cells1

1 study
  1. JAK1 is required for cellular senescence in human cells (shown by JAK1 deficiency, upon TLR3 activation).

    Cellsshown by JAK1 deficiency, upon TLR3 activation

More on Cellular senescence

ISG expression

no changein human cells1

1 study
  1. JAK1 showed no clear effect on ISG expression in human cells (knockdown in senescent fibroblasts).

    Cellsknockdown in senescent fibroblastsfibroblast

Upstream

1

Cellular senescence

upin N. leucodon cells1

1 study
  1. Cellular senescence increases JAK1 in N. leucodon cells during replicative senescence.

    Cellsduring replicative senescencefibroblast

More on Cellular senescence

Associations

2

TPCA-1

mixedin silico1

1 study
  1. TPCA-1 is associated with JAK1 in silico (predicted targeting through small-molecule drug prediction and molecular docking).

    In silicopredicted targeting through small-molecule drug prediction and molecular dockinggastric epithelial cell

More on TPCA-1

Atrial fibrillation

upin humans1OR 1.255

1 study
  1. JAK1 is linked with a higher risk of atrial fibrillation in humans (OR = 1.255, p = 0.043).

    Humans

More on Atrial fibrillation

Funding

1 grant since 2025

American Heart Association

Latest

Dec 2025: 1Jan 2026: 3Feb 2026: 1Mar 2026: 0Apr 2026: 1May 2026: 4Jun 2026: 3Jul 2026: 1Aug 2026: 1Sep 2026: 3Oct 2026: 2Nov 2026: 020 papers in 12 months
Journal of Translational Medicine

Ruxolitinib reduces retinal blood vessel leakage in rats

In Brown-Norway rats with laser-induced eye damage, the drug reduced abnormal blood vessel area and accelerated the recovery of retinal function.In Brown-Norway rats with laser-induced eye damage, the drug reduced abnormal blood vessel area and accelerated the recovery of retinal function.

Rat studyEye
ESC Congress 2026 Abstract

Protein loss made irregular rhythms harder to trigger in mice

Aging mice lacking the protein in heart muscle cells had reduced structural changes in the heart’s upper chambers and lower susceptibility to an experimentally triggered…Aging mice lacking the protein in heart muscle cells had reduced structural changes in the heart’s upper chambers and lower susceptibility to an experimentally triggered irregular heartbeat.

Mouse studyMechanisms
Biomedicine & Pharmacotherapy

Sunitinib selectively killed senescent cells in the lab

A drug screen in human connective-tissue cells linked the selective killing effect to a protein that receives growth signals.A drug screen in human connective-tissue cells linked the selective killing effect to a protein that receives growth signals.

Experiments in human cellsInterventions
International Journal of Molecular Sciences

Drug lowered immune signals but had mixed bone effects in mice

A six-week experiment in 57 female mice modeling accelerated aging found reduced inflammatory signals but no consistent improvement in bone measurements with baricitinib.A six-week experiment in 57 female mice modeling accelerated aging found reduced inflammatory signals but no consistent improvement in bone measurements with baricitinib.

Mouse study · 57 miceBones and joints

See all 51 papers on JAK1